Novel cyclin-dependent kinase 9 (CDK9) inhibitor with suppression of cancer sternness activity against non-small-cell lung cancer

导出原文传递

翻译打印收藏纠错

作者： Wang, Xin ^[1] ; Yu, Chenhua ^[2] ; Wang, Cheng ^[3] ; Ma, Yakun ^[4] ; Wang, Tianqi ; Li, Yao ; Huang, Zhi ; Zhou, Mangian ; Sun, Peiqing ; Zheng, Jianyu ; Yang, Shengyong ; Fan, Yan ; Xiang, Rong

作者单位： Nankai Univ, Sch Med, Dept Med Chem, 94 Weijin Rd, Tianjin 300071, Peoples R China ^[1] Sichuan Univ, West China Hosp, State Key Lab Biotherapy & Canc Ctr, Chengdu 610041, Sichuan ^[2] Tianjin Union Med Ctr, Dept Radiat Oncol, Tianjin 300121, Peoples R China ^[3] Nankai Univ, Collaborat Innovat Ctr Chem Sci & Engn, State Key Lab, Tianjin 300071, Peoples R China ^[4]

关键词 CDK9 CSCs Inhibitor NSCLC

发布时间 2020-07-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

European Journal of Medicinal Chemistry

2019年181卷

111535-111535页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Novel cyclin-dependent kinase 9 (CDK9) inhibitor with suppression of cancer sternness activity against non-small-cell lung cancer

European Journal of Medicinal Chemistry

相似文献

European Journal of Medicinal Chemistry

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Novel cyclin-dependent kinase 9 (CDK9) inhibitor with suppression of cancer sternness activity against non-small-cell lung cancer

European Journal of Medicinal Chemistry

相似文献

European Journal of Medicinal Chemistry

相关期刊

检索历史清除